|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-5-28
|
|
pubmed:abstractText |
Recurrent urothelial cancers are reported to have characteristics similar to those of the primary tumor, with 10% to 25% of low grade tumors recurring as high grade disease. We determined how often grade progression and regression occur and whether abnormalities in p53 protein expression in original tumors are preserved in recurrences.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
169
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2106-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12771728-Aged,
pubmed-meshheading:12771728-Carcinoma, Transitional Cell,
pubmed-meshheading:12771728-Disease Progression,
pubmed-meshheading:12771728-Female,
pubmed-meshheading:12771728-Humans,
pubmed-meshheading:12771728-Immunohistochemistry,
pubmed-meshheading:12771728-Longitudinal Studies,
pubmed-meshheading:12771728-Male,
pubmed-meshheading:12771728-Neoplasm Recurrence, Local,
pubmed-meshheading:12771728-Retrospective Studies,
pubmed-meshheading:12771728-Tumor Suppressor Protein p53,
pubmed-meshheading:12771728-Urinary Bladder Neoplasms
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Grade progression and regression in recurrent urothelial cancer.
|
|
pubmed:affiliation |
Department of Urology, University of Rochester, Rochester, New York 14642, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
